Skip to main content
main-content

Zeitschrift

Journal of Thrombosis and Thrombolysis

A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science

Journal of Thrombosis and Thrombolysis OnlineFirst articles

17.04.2021

Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19

The coronavirus disease 2019 (COVID-19) increases thrombotic risk. The mechanisms that lead to this prothrombotic state are not well established. The main aim was to evaluate the von Willebrand factor (VWF) antigen and plasma ADAMTS13 activity as …

15.04.2021

Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross‐sectional study

Oral anticoagulant therapy (OAT) has increased substantially due to the aging population and prevalence rise of atrial fibrillation (AF). Medication adherence is important to achieve effectiveness and safety of OAT. The study aim was to …

15.04.2021 Open Access

Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study

Venous thromboembolism (VTE) is the third most common cardiovascular disease. Low amount of mitochondrial DNA copy number (mtDNA-CN) has been associated with arterial cardiovascular disease (CVD) and reflects mitochondrial dysfunctions. However …

13.04.2021

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

Female gender has been linked to higher hemorrhagic risk in consideration of more advanced age at presentation and comorbidities The impact of gender on the optimal duration of dual antiplatelet therapy in acute coronary syndromes (ACS) is still …

12.04.2021 | COVID-19 Zur Zeit gratis

Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

It is still debated whether prophylactic doses of low-molecular- weight heparin (LMWH) are always effective in preventing Venous Thromboembolism (VTE) and mortality in COVID-19. Furthermore, there is paucity of data for those patients not …

Aktuelle Ausgaben

Weitere Informationen

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise